Xarelto Bleeding Suits Consolidated in Louisiana MDL
Xarelto lawsuit filings that allege similar injuries caused by the blood thinner have now been centralized in the Eastern District of Louisiana, where a federal multidistrict litigation (MDL) has been created, according to court documents.
An Order on December 12th from the U.S. Judicial Panel on Multidistrict Litigation (JPML) grants a plaintiffs’ request to consolidate claims that similarly allege the anticoagulant’s potential to increase a patient’s risk for life-threatening internal bleeding side effects, along with other serious complications. Xarelto’s manufacturers, Bayer Healthcare Pharmaceuticals and Johnson & Johnson’s Janssen unit, failed to adequately warn about these side effects in their marketing of the medication, plaintiffs allege.
The 21 actions now filed in the U.S. against the makers of Xarelto “present a number of individualized factual issues,” but share many in common, the JPML said in their decision to create a single proceeding. The plaintiffs’ original request for a MDL was issued on October 9th, and was met with opposition by J&J and Bayer, who said the cases differed in the severity of internal bleeding side effects alleged by plaintiffs.
Thousands of Xarelto Bleeding Reports Filed in a Year, Plaintiffs Allege
Xarelto is an oral anticoagulant prescribed to patients who may be susceptible to deep vein thrombosis, pulmonary embolism and strokes in patients with atrial fibrillation, and was approved by the U.S. Food and Drug Administration (FDA) in July 2011.
Since then, the drug has been hailed as a convenient alternative to warfarin, a nearly 50-year old medication that requires patients to undergo routine blood monitoring and monitor their diet, but has also been named in hundreds of adverse event reports. In 2012, the Institute for Safe Medication Practices (ISMP) found more than 1,000 Xarelto side effect reports, 65 of which mentioning patient deaths, filed in the FDA’s Medwatch database. By the end of the year, the number of complaints reached 2,000. During the first quarter of 2013, 680 adverse event reports were filed.
Injuries similar to those alleged in Xarelto lawsuits are also included in claims over Pradaxa, another blood thinner belonging to a class known as direct thrombin inhibitors.
Consider a Xarelto Lawsuit
Contact a Xarelto lawyer today for more about claims filed against Johnson & Johnson and Bayer Healthcare. You may be eligible to file a claim. Call the following number to speak with our attorneys directly: (877) 779-1414.